Gene Editing Corrects <i>In Vitro</i> a G > A <i>GLB1</i> Transition from a GM1 Gangliosidosis PatientDelphine Leclerc, David Gilot|The CRISPR Journal|2023Cited by 4
Gene editing is suitable to treat GM1 Gangliosidosis: a proof-of-concept studyDelphine Leclerc, David Gilot|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2